205 related articles for article (PubMed ID: 31745979)
21. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
Paik PK; Johnson ML; D'Angelo SP; Sima CS; Ang D; Dogan S; Miller VA; Ladanyi M; Kris MG; Riely GJ
Cancer; 2012 Dec; 118(23):5840-7. PubMed ID: 22605530
[TBL] [Abstract][Full Text] [Related]
22. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
25. Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.
Lee YJ; Shim HS; Kang YA; Hong SJ; Kim HK; Kim H; Kim SK; Choi SH; Kim JH; Cho BC
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1937-44. PubMed ID: 20237940
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population.
Skov BG; Høgdall E; Clementsen P; Krasnik M; Larsen KR; Sørensen JB; Skov T; Mellemgaard A
APMIS; 2015 Feb; 123(2):108-15. PubMed ID: 25421919
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
Scoccianti C; Vesin A; Martel G; Olivier M; Brambilla E; Timsit JF; Tavecchio L; Brambilla C; Field JK; Hainaut P;
Eur Respir J; 2012 Jul; 40(1):177-84. PubMed ID: 22267755
[TBL] [Abstract][Full Text] [Related]
28. Never smokers with lung cancer: analysis of genetic variants.
Xiao H; Ding J; Gao S; Yang S; Huang Y
Asian Pac J Cancer Prev; 2011; 12(10):2807-9. PubMed ID: 22320997
[TBL] [Abstract][Full Text] [Related]
29. Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.
Viñolas N; Garrido P; Isla D; Provencio M; Majem M; Artal A; Carcereny E; Garcia Campelo R; Lianes P; De La Peñas R; Felip E
Cancer Invest; 2017 May; 35(5):358-365. PubMed ID: 28350480
[TBL] [Abstract][Full Text] [Related]
30. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
31. Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.
Garassino MC; Gelibter AJ; Grossi F; Chiari R; Soto Parra H; Cascinu S; Cognetti F; Turci D; Blasi L; Bengala C; Mini E; Baldini E; Quadrini S; Ceresoli GL; Antonelli P; Vasile E; Pinto C; Fasola G; Galetta D; Macerelli M; Giannarelli D; Lo Russo G; de Marinis F
J Thorac Oncol; 2018 Aug; 13(8):1146-1155. PubMed ID: 29730379
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
Ng TL; Liu Y; Dimou A; Patil T; Aisner DL; Dong Z; Jiang T; Su C; Wu C; Ren S; Zhou C; Camidge DR
Cancer; 2019 Apr; 125(7):1038-1049. PubMed ID: 30548240
[TBL] [Abstract][Full Text] [Related]
33. The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer.
Toyooka S; Matsuo K; Shigematsu H; Kosaka T; Tokumo M; Yatabe Y; Ichihara S; Inukai M; Suehisa H; Soh J; Kiura K; Fong KM; Lee H; Wistuba II; Gazdar AF; Mitsudomi T; Date H
Clin Cancer Res; 2007 Oct; 13(19):5763-8. PubMed ID: 17908966
[TBL] [Abstract][Full Text] [Related]
34. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
Ou SH
J Clin Pathol; 2013 Oct; 66(10):839-46. PubMed ID: 23661716
[TBL] [Abstract][Full Text] [Related]
36. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
Byeon S; Lee B; Park WY; Choi YL; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Clin Lung Cancer; 2020 May; 21(3):e182-e190. PubMed ID: 31839532
[TBL] [Abstract][Full Text] [Related]
37. EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women.
Taga M; Mechanic LE; Hagiwara N; Vähäkangas KH; Bennett WP; Alavanja MC; Welsh JA; Khan MA; Lee A; Diasio R; Edell E; Bungum A; Jang JS; Yang P; Jen J; Harris CC
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):988-92. PubMed ID: 22523180
[TBL] [Abstract][Full Text] [Related]
38. Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole-slide images.
Ono A; Terada Y; Kawata T; Serizawa M; Isaka M; Kawabata T; Imai T; Mori K; Muramatsu K; Hayashi I; Kenmotsu H; Ohshima K; Urakami K; Nagashima T; Kusuhara M; Akiyama Y; Sugino T; Ohde Y; Yamaguchi K; Takahashi T
Cancer Med; 2020 Jul; 9(13):4864-4875. PubMed ID: 32400056
[TBL] [Abstract][Full Text] [Related]
39. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
40. Nonsmall cell lung cancer in never smokers.
Scagliotti GV; Longo M; Novello S
Curr Opin Oncol; 2009 Mar; 21(2):99-104. PubMed ID: 19532009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]